| 000 | 00993 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517052847.0 | ||
| 264 | 0 | _c20160111 | |
| 008 | 201601s 0 0 eng d | ||
| 022 | _a1365-2036 | ||
| 024 | 7 |
_a10.1111/apt.13373 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGupta, A | |
| 245 | 0 | 0 |
_aLetter: anti-CTLA-4-associated colitis and inflammatory bowel disease pathogenesis--authors' reply. _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _cOct 2015 |
||
| 300 |
_a1032-3 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aCTLA-4 Antigen _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aColitis _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 700 | 1 | _aDe Felice, K M | |
| 700 | 1 | _aLoftus, E V | |
| 700 | 1 | _aKhanna, S | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 42 _gno. 8 _gp. 1032-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/apt.13373 _zAvailable from publisher's website |
| 999 |
_c25265367 _d25265367 |
||